A comprehensive review and the pharmacologic management of primary dysmenorrhea
10.5124/jkma.2020.63.3.171
- Author:
Dayong LEE
1
;
Seul Ki KIM
Author Information
1. Department of Obstetrics and Gynecology, Kyungpook National University Hospital, Daegu, Korea.
- Publication Type:Original Article
- From:Journal of the Korean Medical Association
2020;63(3):171-177
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Dysmenorrhea is the most common gynecologic condition in women during the reproductive period. Severe dysmenorrhea pain affects their social activities, sleep, and quality of life. Nevertheless, the proportion of women with dysmenorrhea do not receive adequate medical counseling or pharmacological treatments. Primary dysmenorrhea is diagnosed clinically, and the secondary causes that can cause pelvic pain should be identified. The treatment of choice for primary dysmenorrhea is non-steroidal anti-inflammatory drugs (NSAIDs). In order to maximize the therapeutic effect, it is necessary to ensure that the appropriate medication is administered in a proper way. NSAIDs can cause adverse effects, including gastrointestinal disorders. If side effects occur or are anticipated with NSAIDs, the use of hormonal contraceptives may be recommended when contraception is considered. In addition to these pharmacological treatments, heat, dietary, and behavioral therapies have been tried and reported to have some effects. However, further research is required for robust conclusions.
